Risk factors influencing seroconversion after inactive SARS-CoV-2 vaccination in people living with obesity

Risk factors influencing seroconversion after inactive SARS-CoV-2 vaccination in people living with obesity

Abstract Introduction To investigate the antibody titers against SARS-CoV-2 spike antigens, and the risk factors affecting antibody levels in people living with obesity (PwO) after inactive SARS-CoV-2 vaccine (Corona Vac) administration. Methods 169 consecutive patients with obesity who visited the...

Full description

Bibliographic Details
Main Authors:	Zehra Kara, Rüveyda Akçin, Ahmet Numan Demir, Harika Oyku Dinc, Bekir Kocazeybek, Volkan Demirhan Yumuk
Format:	Article
Language:	English
Published:	Karger Publishers 2022-08-01
Series:	Obesity Facts
Online Access:	https://www.karger.com/Article/FullText/525555

Similar Items

Antibody Response to inactive SARS-CoV-2 vaccination in a cohort of elderly patients living with obesity
by: Zehra Kara, et al.
Published: (2023-05-01)

Seroconversion after Inactive SARS-CoV-2 Vaccination and Obesity: Correspondence
by: Rujittika Mungmunpuntipantip, et al.
Published: (2022-11-01)

Anti-SARS-CoV-2 IgG and Neutralizing Antibody Levels in Patients with Past COVID-19 Infection: A Longitudinal Study
by: Harika Öykü Dinç, et al.
Published: (2022-05-01)

Humoral and Cellular Immunity to Severe Acute Respiratory Syndrome Coronavirus-2 Vaccination in Patients with Sarcoidosis
by: Ersan Atahan, et al.
Published: (2023-01-01)

SARS CoV-2 Pathogenesis and Immune Response
by: Harika Öykü DİNÇ, et al.
Published: (2020-12-01)

Comparison of SARS-CoV-2 Antibody Levels after a Third Heterologous and Homologous BNT162b2 Booster Dose
by: Nesrin Gareayaghi, et al.
Published: (2022-10-01)

BNT162b2 COVID-19 vaccination elicited protective robust immune responses in pediatric patients with inborn errors of metabolism
by: Tanyel Zubarioglu, et al.
Published: (2023-01-01)

History of Epidemics and COVID-19
by: Pelin YÜKSEL MAYDA, et al.
Published: (2020-12-01)

Obesity: A Gateway Disease with a Rising Prevalence
by: Gema Frühbeck, et al.
Published: (2014-04-01)

Evaluation of the Diagnostic Performance of a SARS-CoV-2 and Influenza A/B Combo Rapid Antigen Test in Respiratory Samples
by: Harika Öykü Dinç, et al.
Published: (2023-03-01)

The Relationship between Gastroduodenal Pathologies and Helicobacter pylori cagL (Cytotoxin-Associated Gene L) Polymorphism
by: Doğukan Özbey, et al.
Published: (2023-04-01)

Seroconversion and adverse reaction of live-attenuated (OKA strain) varicella vaccine
by: Yulchair Ramli, et al.
Published: (2016-09-01)

Differences in the Clinical Presentation of Patients with Adrenocorticotropic Hormone–Dependent Cushing’s Syndrome
by: Zehra Kara, et al.
Published: (2024-04-01)

Assessment of Seroconversion to SARS-CoV-2 in Health Care Unitunit Personnel
by: A. I. Blokh, et al.
Published: (2021-11-01)

Evaluación de la seroconversión de anticuerpos contra SARS-COV-2
by: Diego Fernando López Muñoz, et al.
Published: (2022-07-01)

Can vitamin D status influence seroconversion to SARS-COV2 vaccines?
by: Endrit Shahini, et al.
Published: (2022-12-01)

Seroconversion to mRNA SARS-CoV-2 Vaccines in Hematologic Patients
by: Bruno Fattizzo, et al.
Published: (2022-05-01)

Modeling the cost of inaction in treating obesity in Canada
by: Fang Chen, et al.
Published: (2025-03-01)

CONSIDERATIONS REGARDING THE RISKS OF OBESITY AND PHYSICAL INACTIVITY
by: Constanța Urzeală
Published: (2018-08-01)

The Role of Inflammatory Parameters and Antibody Seroconversion on COVID-19 Outcomes in Patients with Central Obesity
by: Syahidatul Wafa, et al.
Published: (2024-10-01)

Exposed seronegative: cellular immune responses to SARS-CoV-2 in the absence of seroconversion
by: Jay, C, et al.
Published: (2023)

Assessment of Seroconversion after SARS-CoV-2 Vaccination in Patients with Lung Cancer
by: Ioannis P. Trontzas, et al.
Published: (2022-04-01)

Corrigendum: Can vitamin D status influence seroconversion to SARS-COV2 vaccines?
by: Endrit Shahini, et al.
Published: (2023-05-01)

Exposed seronegative: Cellular immune responses to SARS-CoV-2 in the absence of seroconversion
by: Cecilia Jay, et al.
Published: (2023-01-01)

Dynamics of anti-SARS-CoV-2 seroconversion in individual patients and at the population level
by: Alina Szewczyk-Dąbrowska, et al.
Published: (2022-01-01)

Dynamics of anti-SARS-CoV-2 seroconversion in individual patients and at the population level.
by: Alina Szewczyk-Dąbrowska, et al.
Published: (2022-01-01)

European Association for the Study of Obesity (EASO) Position Statement on Medical Nutrition Therapy for the Management of Individuals with Overweight or Obesity and Cancer
by: Giovanna Muscogiuri, et al.
Published: (2024-10-01)

Inactive metallopeptidase homologs: the secret lives of pseudopeptidases
by: Peter J. Lyons
Published: (2024-07-01)

High Incidence of syphilis seroconversion among people living with HIV in Hainan, south China
by: Kaokao Zhu, et al.
Published: (2024-12-01)

Evaluating the effectiveness of anti-tuberculosis treatment by detecting Mycobacterium tuberculosis 85B messenger RNA expression in sputum
by: Ersan Atahan, et al.
Published: (2020-10-01)

All Types Obesity and Physical Inactivity Associated with the Risk of Activity of Daily Living Limitations Among People with Asthma
by: Alhammad SA, et al.
Published: (2022-07-01)

Detection of A2143G, A2142C, and A2142G Point Mutations with Real-Time PCR in Stool Specimens from Children Infected with <i>Helicobacter pylori</i>
by: Nesrin Gareayaghi, et al.
Published: (2022-08-01)

An EASO Position Statement on Multidisciplinary Obesity Management in Adults
by: Volkan Yumuk, et al.
Published: (2014-03-01)

Incidence of Infection among Subjects with Seroconversion
by: Young Jung Kim, et al.
Published: (2022-01-01)

Healthcare Worker Seroconversion in SARS Outbreak
by: Pierce K. H. Chow, et al.
Published: (2004-02-01)

Obesity Management in Europe: Current Status and Objectives for the Future
by: Magdalena F. Uerlich, et al.
Published: (2016-08-01)

SARS-CoV-2 Seroconversion in an Adult Horse with Direct Contact to a COVID-19 Individual
by: Nicola Pusterla, et al.
Published: (2022-05-01)

Is SARS‐CoV‐2 seroconversion a risk factor for severe and acute psychiatric symptoms in children?
by: Anaël Ayrolles, et al.
Published: (2022-06-01)

On the caveats of a multiplex test for SARS-CoV-2 to detect seroconversion after infection or vaccination
by: Lorena O. Fernandes-Siqueira, et al.
Published: (2022-06-01)

Intrafamilial Exposure to SARS-CoV-2 Associated with Cellular Immune Response without Seroconversion, France
by: Floriane Gallais, et al.
Published: (2021-01-01)